Related Experiment Video

Updated: May 25, 2026

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

Enhanced apoptosis-inducing function of MDA-7/IL-24 RGD mutant via the increased adhesion to tumor cells

Dong-Sheng Pei1, Zhi-Xia Yang, Bao-Fu Zhang

  • 1Jiangsu Key Laboratory of Biological Cancer Therapy, Xuzhou Medical College, Xuzhou, China.

Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|January 18, 2012
PubMed

Insights

Engineered RGD-IL-24 protein enhances tumor cell apoptosis by targeting integrin α(v)β(3). This targeted approach boosts therapeutic efficacy against cancer cells while sparing normal cells, offering a promising new cancer treatment strategy.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Biotechnology

Background:

  • Melanoma differentiation-associated gene-7 (mda-7)/interleukin-24 (IL-24) induces apoptosis in tumor cells, but its efficacy is limited by low tumor cell adhesion.
  • Integrin α(v)β(3), expressed on solid tumor cells, binds to arginine-glycine-aspartic acid (RGD) motifs, enhancing cell adhesion.

Purpose of the Study:

  • To construct a tumor-targeting RGD-IL-24 gene to improve IL-24's apoptosis-inducing capacity.
  • To evaluate the therapeutic efficacy of RGD-IL-24 on various tumor cell lines and normal cells.

Main Methods:

  • Overlapping polymerase chain reaction (PCR) was used to create the RGD-IL-24 mutant.
  • Therapeutic efficacy was assessed using MTT assay, Annexin V, and Hoechst 33258 staining.
  • Changes in pro-apoptotic (bax) and anti-apoptotic (bcl-2) protein ratios were analyzed.

Main Results:

  • RGD-IL-24 expression levels were comparable to IL-24.
  • RGD-IL-24 significantly enhanced apoptosis in tumor cell lines (MCF-7, HeLa, HepG2) compared to IL-24.
  • Apoptosis induction was specific to tumor cells, with no significant effect on normal human lung fibroblast (NHLF) cells.
  • RGD-IL-24 increased the bax/bcl-2 ratio in tumor cells but not in NHLF cells.

Conclusions:

  • RGD-IL-24 effectively enhances tumor cell apoptosis through targeted adhesion.
  • The RGD-IL-24 construct shows promising potential as a novel therapeutic agent for cancer treatment.

More Related Videos

Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells09:57

Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells

Published on: January 29, 2019

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...